Novel mPGES-1 inhibitors as next generation of anti-inflammatory drugs - 2122
- Technology Benefits
- Inventioninhibits mPGES-1 activity with greater potency than mPGES-1 inhibitors in orderto treat inflammatory disorders. Invention should limit adverse side effectsassociated with traditional anti-inflammatory agents (i.e. ulcers,gastrointestinal bleeding).
- Detailed Technology Description
- None
- *Abstract
-
None
- Country/Region
- USA
For more information, please click Here

